SAGE Sage Therapeutics Stock Price

Graphic logo of Sage Therapeutics Inc (SAGE)

The visualized price action of Sage Therapeutics, Inc. (SAGE) reflects market expectations for a business that generates revenue by developing advanced therapies for depressive states through hospital and pharmacy channels. The current indicator stands at 8.73. Growth prospects rely on insurance coverage for Zurzuvae and Zulresso, as well as the development of methods to combat Huntington's disease. Cost optimization has reduced losses, although liquidity remains moderate.

SAGE - Sage Therapeutics Inc Price Rate Chart over the range 07/04/2022 - 08/16/2025

Sage Therapeutics, Inc (SAGE) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Analysis of all company metrics:sagerx.com SAGE
Signature product of Sage Therapeutics Inc.

The price reflects the market equilibrium between supply and demand, serving as the quantitative equivalent of investors' aggregate expectations regarding the future cash flows of Sage Therapeutics, Inc. (SAGE). By analyzing the price action history, one can assess how the market reacts to the operational resilience of the business, secured by the diversification of production sites and the optimization of international supply chains for innovative neuropsychiatric drugs.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price ANVS (Annovis Bio Inc)|gracetx.com (GRCE) - Market Price|AIFF - Price Chart|anewmeds.com (KLTO) - Stock Quotes|NeuroSense Therapeutics, Ltd. (NRSN) - Price Chart|Market Price Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Price Chart MetaVia|Share Price NRXS (NeurAxis Inc.)|Stock Price HSDT|PASG: Quote Chart|Neuphoria Therapeutics, Inc. - Stock Quotes|NERV: Share Price|athira.com - Stock Price|ADXN - Stock Price|ALZN: Stock Price|CYCN - Market Chart|PTIX (Protagenic Therapeutics, Inc.) - Stock Price|pasitheaclinics.com (KTTA) - Market Chart|Price Chart Cortigent Inc (CRGT)|Avenue Therapeutics, Inc. - Share Price|Price Chart Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Stock Quotes|chromocell.com - Stock Price|Market Price Eliem Therapeutics, Inc.|ITCI: Stock Price|LBPH - Market Chart|Price Chart Marinus Pharmaceuticals|NKGN: Price Performance Chart|Price Chart NeuroBo Pharmaceuticals Inc (NRBO)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel